IL18 and Menkes disease: Thus, several short-term interventional studies with MD have shown an improvement in inflammatory biomarkers such as MCP-1, CRP, E and P-selectin, VCAM-1, ICAM-1, TNF-α, IL-6, IL-7, IL-8, IL-10, and IL-18 [18,20].